Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

7.45
Delayed Data
As of Apr 24
 +0.08 / +1.09%
Today’s Change
3.71
Today|||52-Week Range
13.88
+63.38%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$80.6M

Company Description

Oramed Pharmaceuticals, Inc. is engaged in the research and development of pharmaceutical solutions for the use of orally ingestible capsules or pills for delivery of polypeptides, such as insulin and vaccines. Its products are oral insulin and oral Exenatide capsules. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in Jerusalem, Israel.

Contact Information

Oramed Pharmaceuticals, Inc.
Hi-Tech Park 2/5
Jerusalem -- 91390
P:(722) 566-0001
Investor Relations:
972547924438

Employees

Shareholders

Other institutional7.82%
Individual stakeholders24.48%
Mutual fund holders2.17%

Top Executives

Nadav KidronPresident, Chief Executive Officer & Director
Joshua HexterChief Operating Officer & VP-Business Development
Yifat ZommerChief Financial Officer, Secretary & Treasurer
Miriam KidronDirector, CTO, Chief Medical & Scientific Officer
Roy EldorDirector-Medical Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account